Electrophoresis Equipment And Supplies Market: Market Size & Forecast 2026

The electrophoresis equipment and supplies market comprises a range of products used to separate charged biological molecules under an electric field, including gel electrophoresis systems, capillary electrophoresis instruments, and associated reagents and consumables. Reagents and consumables represent the largest revenue segment due to their recurring, repeat-purchase nature, while instruments account for a substantial portion of new equipment sales. Gel electrophoresis systems remain the most widely used technology, though capillary electrophoresis is gaining share in clinical and forensic applications for its speed and automation capabilities.

• •The market is structured around two primary product categories: instruments (including gel and capillary electrophoresis systems) and consumables (gels, buffers, reagents, and markers)
• •North America currently holds the largest regional market share, supported by substantial biotechnology and pharmaceutical R&D expenditure and a well-established research infrastructure
• •Asia-Pacific is expected to register the fastest regional growth rate, driven by expanding pharmaceutical manufacturing, increasing academic research funding, and growing diagnostic laboratory networks

Biotechnology and pharmaceutical companies are increasing R&D investments in genomics and proteomics, directly fueling demand for electrophoresis workflows used in drug discovery and development pipelines. The global shift toward personalized medicine and companion diagnostics requires precise protein and nucleic acid characterization, for which electrophoresis remains a foundational analytical technique. Additionally, the expansion of clinical molecular diagnostics and forensic DNA analysis continues to drive adoption of electrophoresis systems in hospital and government laboratories worldwide.

• •Advancements in genomics research, including gene therapy and next-generation sequencing workflows, depend on electrophoresis for validation and quality control steps
• •Growing forensic DNA analysis requirements from law enforcement agencies, coupled with expanding clinical laboratory networks for genetic testing, are driving instrument and reagent demand
• •Rising prevalence of genetic and chronic diseases is increasing demand for molecular diagnostic testing, with electrophoresis serving as a critical component of many diagnostic assays

By product, reagents and consumables dominate the market, typically accounting for over 40 percent of total revenue due to their essential and high-volume usage. Instruments, including gel electrophoresis systems, capillary electrophoresis instruments, and imaging systems, represent the equipment segment, with gel systems holding the largest share. Geographically, North America leads, followed by Europe, while Asia-Pacific and Latin America represent high-growth markets as research and clinical infrastructure expands.

• •Academic and research institutions remain the largest end-user category, though clinical diagnostics and pharmaceutical companies are expanding their adoption at above-average rates
• •Gel electrophoresis systems account for a dominant share of the instrument segment, with agarose and polyacrylamide gel-based systems being the most prevalent
• •Key regional markets include the United States, Germany, the United Kingdom, Japan, China, and India, with emerging economies investing heavily in expanding laboratory infrastructure

What are the recent trends and outlook?

Workflow automation and integration with laboratory information management systems are becoming increasingly important as laboratories seek to improve throughput and reduce manual variability. Capillary electrophoresis is steadily replacing traditional gel-based methods in clinical and forensic settings due to its superior speed, resolution, and compatibility with automation. As biopharmaceutical development expands and molecular diagnostics becomes further integrated into routine healthcare, demand for reliable and high-performance electrophoresis solutions is anticipated to sustain the market's growth trajectory through the forecast period.

• •Automation of electrophoresis workflows, including automated sample preparation and analysis systems, is becoming a standard expectation in both research and clinical environments
• •Microfluidic and miniaturized electrophoresis technologies are gaining adoption for their efficiency in sample analysis, reduced reagent consumption, and suitability for point-of-care applications
• •Expansion of biopharmaceutical manufacturing and personalized medicine initiatives, along with growing forensic and clinical testing volumes, is expected to drive consistent market demand through 2035